Parth C. Patel

Employment

• Morsani College of Medicine Resident PGY-3
  2021 - 2024

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis
  Blood Cancer Discovery 2024 DOI: 10.1158/2643-3230.bcd-23-0210
  +Save
• Complement‐mediated thrombotic microangiopathy treated with anticomplement protein 5 therapy, a retrospective study
  European Journal of Haematology 2024 DOI: 10.1111/ejh.14136
  +Save
• Drivers of deep molecular response and long‐term outcomes in patients with core binding factor acute myeloid leukemia
  American Journal of Hematology 2023 DOI: 10.1002/ajh.27092
  +Save
• Aplastic Anemia: Insight from a Single Center Experience
  Blood 2023 DOI: 10.1182/blood-2023-178952
  +Save
• MYC-Alarmin Axis As a Novel Oncogenic Driver in a Subgroup of Triple Negative Myeloproliferative Neoplasms
  Blood 2023 DOI: 10.1182/blood-2023-174383
  +Save
• A Novel Subtype of Myeloproliferative Neoplasms Driven by a MYC-Alarmin Axis
  2023 DOI: 10.1101/2023.09.25.559138
  +Save
• MDS-420 Aplastic Anemia: Insight from a Single Center Experience
  Clinical Lymphoma Myeloma and Leukemia 2023 DOI: 10.1016/s2152-2650(23)01187-4
  +Save
• POSTER: MDS-420 Aplastic Anemia: Insight from a Single Center Experience
  Clinical Lymphoma Myeloma and Leukemia 2023 DOI: 10.1016/s2152-2650(23)00593-1
  +Save
• Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience.
  Journal of Clinical Oncology 2023 DOI: 10.1200/jco.2023.41.16_suppl.e20055
  +Save
• Poster: AML-488 Impact of Somatic Mutations on Treatment Response and Outcomes in Patients With Core Binding Factor Acute Myeloid Leukemia
  ASH Annual Meeting 2022 DOI: 10.1016/s2152-2650(22)00822-9
  +Save